World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33448852

Number of visits today: 7762

Number of downloads: 16634015

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Panaccione R, Abreu MT, Lazariciu I, Mundayat R, Lawendy N, Salese L, Woolcott JC, Sands BE, Chaparro M. Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open-label, long-term extension study, OCTAVE open. Aliment Pharmacol Ther 2022;55:1534-44. [PMID: 35246988 DOI: 10.1111/apt.16848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

For:

Panaccione R, Abreu MT, Lazariciu I, Mundayat R, Lawendy N, Salese L, Woolcott JC, Sands BE, Chaparro M. Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open-label, long-term extension study, OCTAVE open. Aliment Pharmacol Ther 2022;55:1534-44. [PMID: 35246988 DOI: 10.1111/apt.16848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

Number	Citing Articles
1	Chaparro M, Acosta D, Rodríguez C, Mesonero F, Vicuña M, Acosta MB, Fernández-Clotet A, Martínez ÁH, Arroyo M, Vera I, Ruiz-Cerulla A, Sicilia B, Cabello Tapia MJ, Villafranca CM, Castro-Poceiro J, Cadilla JM, Sierra-Ausín M, Vázquez Morón JM, Lidón RV, Bermejo F, Royo V, Calafat M, González-Muñoza C, Carnerero EL, Marcos NM, Torrealba L, Alonso-Galán H, Benítez JM, Nieto YB, Diz-Lois Palomares MT, García MJ, Muñoz JF, Armesto González EM, Calvet X, Hernández-Camba A, Madrigal Domínguez RE, Menchén L, Pérez Calle JL, Piqueras M, Sadornil CD, Botella B, de Jesús Martínez-Pérez T, Ramos L, Rodríguez-Grau MC, San Miguel E, Fernández Forcelledo JL, Fradejas Salazar PM, García-Sepulcre M, Gutiérrez A, Llaó J, Abizanda ES, Boscá-Watts M, Iyo E, Keco-Huerga A, Bonil CM, González EP, Pérez-Galindo P, Varela P, Gisbert JP. Real-world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness and safety. Am J Gastroenterol 2022. [PMID: 36716287 DOI: 10.14309/ajg.0000000000002145] [Reference Citation Analysis]
2	Kakiuchi T, Yoshiura M. Japanese pediatric patient with refractory steroid-resistant ulcerative colitis successfully treated with Tofacitinib: A case report. Medicine (Baltimore) 2022;101:e31757. [PMID: 36397383 DOI: 10.1097/MD.0000000000031757] [Reference Citation Analysis]
3	Wang W, Pekow J. Editorial: response to tofacitinib is associated with high rates of long-term treatment persistence. Aliment Pharmacol Ther 2022;55:1222-3. [PMID: 35429025 DOI: 10.1111/apt.16891] [Reference Citation Analysis]